InMode (INMD) Profit After Tax Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | -36.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.48% |
| Dec 31, 2025 | -67.35% |
| Sep 30, 2025 | -57.12% |
| Jun 30, 2025 | 12.28% |
| Mar 31, 2025 | -23.19% |
| Dec 31, 2024 | 50.04% |
| Sep 30, 2024 | 9.61% |
| Jun 30, 2024 | -61.73% |
| Mar 31, 2024 | -41.50% |
| Dec 31, 2023 | 46.30% |
| Sep 30, 2023 | -4.65% |
| Jun 30, 2023 | 41.29% |
| Mar 31, 2023 | 30.77% |
| Dec 31, 2022 | -28.43% |
| Sep 30, 2022 | 9.10% |
| Jun 30, 2022 | 7.63% |
| Mar 31, 2022 | 15.81% |
| Dec 31, 2021 | 46.06% |
| Sep 30, 2021 | 67.94% |
| Jun 30, 2021 | 376.98% |
| Mar 31, 2021 | 312.05% |
| Dec 31, 2020 | 87.43% |
| Sep 30, 2020 | 61.19% |
| Jun 30, 2020 | -45.82% |
| Mar 31, 2020 | -36.10% |
| Dec 31, 2019 | 8,887.67% |
| Sep 30, 2019 | 91.24% |
| Jun 30, 2019 | 108.91% |